CompletedNot Applicable

Atopic Dermatitis (AD) and Food Allergy

United States62 participantsStarted 2017-06-12

Plain-language summary

This is a prospective, single center, clinical mechanistic pilot clinical research study. Participants will not receive any investigational agent. The investigators will examine whether children with atopic dermatitis (AD) and food allergy have a different skin barrier, microbiome, epidermal transcriptome, and epidermal lipid composition than children with AD and no food allergy and non-atopic (NA) children. Participation involves a single study visit.

Who can participate

Age range4 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓Parent/guardian must be able to understand and provide informed consent and participant provide assent as applicable per Institutional Review Board (IRB) guidelines and regulations;
✓Active Atopic Dermatitis (AD) without a history or current manifestations of eczema herpeticum (EH), as diagnosed using the Atopic Dermatitis Registry

What they're measuring

The Transepidermal Water Loss (TEWL) Area Under the Curve

Timeframe: Visit 1 (Day 1)

Trial details

NCT IDNCT03168113

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)

Sponsor typeNIH

Study typeOBSERVATIONAL

Primary completion2018-01-31

View on ClinicalTrials.gov More Atopic Dermatitis (AD) trials